News

We are happy to share below a new publication which shows the excellent performance of the FREND^TM COVID-19 Ag assay (NanoEntek, South Korea) as a frontline test for SARS-CoV-2 identification in comparison to the available molecular techniques and to the STANDARD F COVID-19 Ag FIA test, a rapid fluorescent immunoassay test currently used in clinical practice.

We would like to inform you today that BÜHLMANN Laboratories AG now has the fastest SARS-CoV-2 Antigen (Ag) rapid test on the market in its portfolio, which has just been validated and approved by the BAG.

From 2-5 June 2021, the 6th World Congress of Paediatric Gastroenterology, Hepatology and Nutrition (WCPGHAN) will take place as a fully virtual event. BÜHLMANN will be present with a virtual booth sharing the product portfolio for diagnosis and therapeutic monitoring of IBD patients.

We would like to celebrate with you today`s World IBD Day 2021 and raise awareness for people suffering from Inflammatory Bowel Disease (IBD).